Biosynthetic Regulation of Secondary Metabolites in Actinomycetes

Actinomycetes represent a prolific group of filamentous bacteria renowned for their capacity to produce an extraordinary array of secondary metabolites, including antibiotics, anticancer agents and immunosuppressants. These compounds are encoded within discrete biosynthetic gene clusters (BGCs) whose expression is tightly governed by multilayered regulatory networks. At the heart of this regulation lie small diffusible signalling molecules—most notably γ-butyrolactones and butenolides—which function as autoinducers to synchronise metabolite production with cellular development and environmental conditions. Pathway-specific transcriptional activators and repressors interpret these signals, while global regulators integrate nutrient availability, stress responses and quorum cues to fine-tune expression of BGC-encoded enzymes. Cross-talk between distinct clusters can occur through shared regulators or common signalling ligands, leading to hierarchical or coordinated activation of multiple pathways. Recent advances in genome mining and synthetic biology have further revealed the potential to awaken cryptic BGCs by manipulating regulatory elements or by heterologous expression of key transcription factors. Such strategies not only deepen our understanding of natural regulatory logic but also open new avenues to engineer actinomycetes for enhanced or novel compound production.

Research from Nature Portfolio

Complete sequencing of the Streptomyces rochei genome, encompassing a linear chromosome and three characteristic linear plasmids, has illuminated the organisational principles of secondary-metabolite regulation. Bioinformatic analysis uncovered over 35 BGCs, including clusters for macrolide and azoxyalkene compounds, alongside regulatory genes located on both chromosome and plasmids. This work highlights how plasmid-borne regulator–effector pairs can interact with chromosomal networks to modulate metabolite biosynthesis and suggests plasmid-chromosome interplay as a versatile layer of control in actinomycetes.

Biosynthetic Regulation of Secondary Metabolites in Actinomycetes publication trend

The graph below shows the total number of articles in biosynthetic regulation of secondary metabolites in actinomycetes across all publications each year (not limited to Nature Index journals).

Technical terms

Actinomycetes: Filamentous Gram-positive bacteria known for producing a vast array of secondary metabolites.

Secondary metabolite: A bioactive small molecule not required for primary growth but often conferring ecological advantages.

Biosynthetic gene cluster (BGC): A contiguous set of genes encoding enzymes and regulators for the synthesis of a specific secondary metabolite.

γ-Butyrolactones: Small lactone molecules serving as quorum-sensing autoinducers that trigger antibiotic biosynthesis in Streptomyces.

Butenolides: Structurally related signalling compounds that regulate secondary-metabolite production via cognate receptor proteins.

Quorum sensing: Cell-to-cell communication mechanism by which bacteria coordinate gene expression in response to population density.

References

1. The genome sequence of Streptomyces rochei 7434AN4, which carries a linear chromosome and three characteristic linear plasmids. Scientific Reports (2019).
2. Regulation of Antibiotic Production by Signaling Molecules in Streptomyces. Frontiers in Microbiology (2019).
3. Identification of a butenolide signaling system that regulates nikkomycin biosynthesis in Streptomyces. Journal of Biological Chemistry (2018).
4. “Pseudo” γ-Butyrolactone Receptors Respond to Antibiotic Signals to Coordinate Antibiotic Biosynthesis*. Journal of Biological Chemistry (2010).